RE: what the....23 Jul 2020 16:14
Septembers Results will indeed be interesting, because unlike many that have been making statements, based on guess work it seems, to be fair CLIN seem to have resisted making much of a statement regarding expectations due to covid scenario, whilst many will simply see pharma and assume the sector as a whole should be doing good because of money poured in for covid related things, CLIN does have a much more broad business model, and with certain patent protections ending and generic versions of to products becoming available, exactly where the results will fall in the good to bad scale is going to make for interesting reading.
Personally, i think they will be ok, perhaps not stella, but certainly better than a number of companies lately.
The stop loss thing is an interesting scenario, I know that when limit sells/stop losses are in place, those shares can't be loaned out for shorting purposes, but i'm not sure if the MMs will know where those limits are placed, that would require the data to be divulged by the brokers, and i'm not sure if that's allowed.